CytomX Therapeutics
About:
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.
Website: http://www.cytomx.com
Twitter/X: cytomxinc
Top Investors: Wellington Management, Deerfield, Cormorant Asset Management, Casdin Capital, Perceptive Advisors
Description:
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. Their mission, alone and with the help of partners, is to provide patients with more effective and less toxic therapies for severe illnesses such as cancer and inflammatory diseases.
$345M
$100M to $500M
South San Francisco, California, United States
2008-01-01
Fred Gluck, Nancy E. Stagliano, Patrick Daugherty
101-250
2021-01-21
Public
© 2025 bioDAO.ai